TNF-alpha Inhibition May Improve Psoriasis, CVD RiskTNF-alpha Inhibition May Improve Psoriasis, CVD Risk

Dr. Graeme M. Lipper reviews a study showing that etanercept produced a reduction in 6 proinflammatory markers. Medscape Dermatology
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Dermatology Viewpoint Source Type: news